Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer's disease prior to amyloid-beta deposition delays the disease's pathological development and ameliorates cognitive decline.

Authors:
Huang Z; Gong Z; Lin Y; Yang F; Chen W and 5 more

Journal:
Front Aging Neurosci

Publication Year: 2024

DOI:
10.3389/fnagi.2024.1267780

PMCID:
PMC10861656

PMID:
38352237

Journal Information

Full Title: Front Aging Neurosci

Abbreviation: Front Aging Neurosci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics & Gerontology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This project was supported by the Guangzhou Municipal Science and Technology Project (201904010066), the Natural Science Foundation of Guangdong Province (2023A1515012780), and the Science and Technology Planning Project of Guangdong Province (2020A1414040027)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025